Increasing prevalence of chronic diseases and rising healthcare expenditure are anticipated to fuel the growth of the global optical coherence tomography market at a CAGR of 15.06% during the forecast period of 2023 to 2030

Market Research Future (MRFR) has published a cooked research report on the “Optical Coherence Tomography Market” that contains information from 2018 to 2030.  The Optical Coherence Tomography Market is estimated to register a CAGR of 15.06% during the forecast period of 2023 to 2030.

Market Highlights

The global Optical Coherence Tomography Market is accounted to register a CAGR of 15.06% during the forecast period and is estimated to reach USD 6.14 billion by 2030.

Optical Coherence Tomography (OCT) is a non-invasive imaging technique that uses light waves to capture high-resolution cross-sectional images of biological tissues. It is commonly used in ophthalmology for retinal imaging but has applications in other medical fields such as cardiology, dermatology, and gastroenterology.

Segment Analysis

The global Optical Coherence Tomography Market has been segmented based Technology, Application, Type of Devices

Based on technology, the market segments of optical coherence tomography includes Sd-Oct and Swept-Source Oct. The Sd-Oct segment held the majority share in 2022, contributing around ~65-67% to the market revenue of optical coherence tomography. Sd-Oct is an interferometric technology capable of providing depth-resolved tissue data structures encrypted in the scale and deferral of backscattered light by analyzing the spectrum of the sequence of the interference fringe.  

Based on application, the optical coherence tomography market segmentation includes cardiology, ophthalmology, and dermatology. The ophthalmology segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Ophthalmology is expected to increase as the incidence of choroidal and retinal disorders rises, leading to increased use of optical coherence tomography imaging and diagnostic devices by ophthalmologists.

The optical coherence tomography market data has been bifurcated by type of devices into handheld, tabletop, and catheter-based Oct devices. The handheld segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period 2022-2030. Handheld OCT devices use Microelectromechanical Systems (MEMS) and 3D imaging to assist in the early detection of various eye disorders, including macular degeneration, diabetic retinopathy, and glaucoma. Therefore, the management of bedside monitoring will be enhanced by portable OCT devices in the coming years. As a result, this segment's profitable growth can be attributed to increased demands for pharmacokinetic services to help with toxicology tests for IND-enabling studies.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of: Optical Coherence Tomography Market Research Report

Regional Analysis

The global Optical Coherence Tomography Market , based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World . The North American Optical Coherence Tomography market accounted for USD 1.05 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. The region's growth is fueled by a growing senior population, increased approvals and R&D investments, a preference for adopting newer products in the United States, hospital expansion, and a well-established healthcare infrastructure.

The European optical coherence tomography market accounts for the second-largest market share, owing to increased awareness about the early detection of glaucoma and other diseases associated with ocular eye pressure and market adoption of new products. For example, according to the Prevalence & Incidence of Diabetic Retinopathy (DR) in the U.K. Population of Gloucestershire, in May 2021, 35,873 adults with diabetes underwent at least one diabetic retinopathy examination. In Europe, optical coherence tomography has proven helpful in various medical fields, especially ophthalmology.  

The Asia-Pacific Optical Coherence Tomography Market is expected to grow at the fastest CAGR from 2022 to 2030. The rapid regional growth can be attributed to several factors, including an increase in the prevalence of chronic diseases, increased adoption of advanced technologies, a large senior population pool, increased reimbursement for surgical procedures, and a strong preference for minimally invasive procedures over traditional methods. Besides, rising awareness about eye disorders is expected to drive the Asia Pacific optical coherence tomography industry growth throughout the forecast period. Moreover, China’s market of optical coherence tomography held the largest market share, and the Indian market of optical coherence tomography was the fastest-growing market in the Asia-Pacific region.

Key Players:

MRFR recognizes the following companies as the key players in the global Optical Coherence Tomography Market  — Carl Zeiss AG, Alcon, Abbott Laboratories, Terumo Corporation, Koninklijke Philips N.V., Braun Melsungen AG, Boston Scientific Corporation, Topcon Corporation, NIDEK Co. Ltd, Novacam Technologies Inc

Key Findings of the Study

• The North American Optical Coherence Tomography market accounted for USD 1.05 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period.


• Based on technology, the market segments of optical coherence tomography includes Sd-Oct and Swept-Source Oct. The Sd-Oct segment held the majority share in 2022, contributing around ~65-67% to the market revenue of optical coherence tomography.


• Carl Zeiss AG, Alcon, Abbott Laboratories, Terumo Corporation, Koninklijke Philips N.V., Braun Melsungen AG, Boston Scientific Corporation, Topcon Corporation, NIDEK Co. Ltd, Novacam Technologies Inc